Early studies of tau PET in DS revealed that higher tau burden corresponded with mild cognitive impairment[16] and that tau PET was significantly associated with cortical atrophy[32] and accelerated longitudinal decline in cognition[33]. The gene discussed is MAPT; the disease is Cognitive impairment.